Gastroenterology News and Research

RSS

Gastroenterology is the branch of medicine where the digestive system and its disorders are studied.

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

26 Jul 2022

NYU Langone ranked as the top academic health system in the U.S.

NYU Langone Health is the top hospital in New York State and No. 3 in the country, according to U.S. News & World Report's annual "Best Hospitals" Honor Roll released today.

26 Jul 2022

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

25 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Grant funds research that investigates relationships between certain fungi and specific cancers

Dr. Iliyan D. Iliev, an associate professor of immunology and microbiology in the Division of Gastroenterology and Hepatology and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease at Weill Cornell Medicine, has been awarded a five-year, $1.25 million CRI Lloyd J. Old STAR (Scientists Taking Risks) Program grant from Cancer Research Institute (CRI).

19 Jul 2022

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Patients hospitalized with COVID-19 with high estimated blood viscosity are at higher risk of death from complications. High blood viscosity impairs flow to small vessels and increases the risk of blood clots. This measure of blood thickness can be used as a predictor of mortality.

18 Jul 2022

Mount Sinai receives $4.2 million to establish a Proteogenomic Data Analysis Center

The Office of Cancer Clinical Proteomics Research at the National Cancer Institute has awarded $4.2 million over five years to Mount Sinai researchers establishing a Proteogenomic Data Analysis Center to advance cancer research and treatments.

13 Jul 2022

Study identifies a protein that plays key role in protecting the gastrointestinal tract from inflammation

A protein called Zbtb46, expressed by specialized immune cells, has a major role in protecting the gastrointestinal tract from excessive inflammation, according to a study from researchers at Weill Cornell Medicine.

13 Jul 2022

Surveillance program for high risk patients aids in early detection of pancreatic cancer

Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study directed by experts at the Johns Hopkins Kimmel Cancer Center.

13 Jul 2022

Researchers develop an AI system to classify IBD neoplasia lesions accurately

The incidence of inflammatory bowel disease (IBD) - an intractable disease characterized by chronic inflammation of the gastrointestinal (GI) tract - has increased significantly in Japan.

13 Jul 2022

Specific form of age-related macular degeneration linked to cardiovascular disease and stroke risk

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.

12 Jul 2022

Nuclear stress testing can help shape physicians' decision to refer patients for heart procedures

Patients identified by nuclear stress testing as having severe stress-induced myocardial ischemia (lack of blood flow to the heart) are likely to benefit from heart bypass surgery or angioplasty, while those with mild or no ischemia are not, according to a new study from the Icahn School of Medicine at Mount Sinai.

11 Jul 2022

Black individuals may be more vulnerable to atherosclerosis early in life than young Hispanic adults

A unique Mount Sinai study focused on a multi-ethnic, underserved community in New York City shows that young Black adults are twice as likely to have atherosclerosis as similarly situated young Hispanic adults.

11 Jul 2022

Artificial Intelligence-based smartphone app for characterizing stool form

In a recent study published in the American Journal of Gastroenterology, researchers at Cedars-Sinai Medical Center in the United States evaluated an artificial intelligence (AI)-based smartphone application (app) trained to assess a patient's stool characteristics.

10 Jul 2022

Researchers discover the first effective drug to treat rare, genetic liver disease

8 Jul 2022

New method helps determine alcohol consumption in fatty liver disease

It is important to know whether patients have non-alcoholic fatty liver disease (NAFLD) or alcohol-related liver disease (ALD), as this distinction plays a key role in treatment and prognosis but cannot be reliably determined by established diagnostic means.

5 Jul 2022

Machine-learning algorithms can help distinguish acute cholangitis and alcohol-associated hepatitis

Acute cholangitis is a potentially life-threatening bacterial infection that often is associated with gallstones. Symptoms include fever, jaundice, right upper quadrant pain, and elevated liver enzymes.

1 Jul 2022

Study finds above-average rates of mortality from gastric cancer in South Florida

South Florida counties have above-average rates of mortality from gastric cancer, according to a new study published in the journal Gastroenterology by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

29 Jun 2022

Immune particles from llama blood could offer protection against several COVID-19 variants

Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses including SARS-CoV-2 and SARS-CoV-1, which was responsible for the 2003 SARS outbreak.

29 Jun 2022

NYU Langone Health continues to broaden access to high-quality care with recent expansions

NYU Langone Health continues to broaden access to high-quality primary and specialty care with recent expansions on Long Island and in Brooklyn and southeast Florida.

28 Jun 2022

Gastroenterology News and Research

Further Reading

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

NYU Langone ranked as the top academic health system in the U.S.

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Grant funds research that investigates relationships between certain fungi and specific cancers

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Mount Sinai receives $4.2 million to establish a Proteogenomic Data Analysis Center

Study identifies a protein that plays key role in protecting the gastrointestinal tract from inflammation

Surveillance program for high risk patients aids in early detection of pancreatic cancer

Researchers develop an AI system to classify IBD neoplasia lesions accurately

Specific form of age-related macular degeneration linked to cardiovascular disease and stroke risk

Nuclear stress testing can help shape physicians' decision to refer patients for heart procedures

Black individuals may be more vulnerable to atherosclerosis early in life than young Hispanic adults

Artificial Intelligence-based smartphone app for characterizing stool form

Researchers discover the first effective drug to treat rare, genetic liver disease

New method helps determine alcohol consumption in fatty liver disease

Machine-learning algorithms can help distinguish acute cholangitis and alcohol-associated hepatitis

Study finds above-average rates of mortality from gastric cancer in South Florida

Immune particles from llama blood could offer protection against several COVID-19 variants

NYU Langone Health continues to broaden access to high-quality care with recent expansions

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News